Compositions for the inactivation of virus replication and methods of making and using the same
Provided herein are recombinant constructs, vectors and expression cassettes including a first promoter which is suitably a tRNA promoter operably connected to a first polynucleotide encoding a first single guide RNA and a second promoter operably connected to a second polynucleotide encoding a Cas9 polypeptide. The first single guide RNA includes a first portion complementary to a strand of a target sequence of a DNA virus and a second portion capable of interacting with the Cas9 polypeptide. Also provided are codon optimized Staphylococcus aureus derived Cas9 polynucleotides and polypeptides with nuclear localization signals and optionally an epitope tag. Also provided are constructs for production of sgRNAs including a tRNA. Methods of inhibiting viral replication, inhibiting expression of a target sequence from a virus or treating a viral infection or viral induced cancer using the compositions are also provided.
1. A recombinant Sau Cas9 construct comprising a promoter operably connected to a polynucleotide encoding a recombinant Sau Cas9 polypeptide, the polynucleotide comprising SEQ ID NO: 55.
2. The recombinant Sau Cas9 construct of claim 1 , further comprising at least one of a poly (A) addition site, an intron and a nuclear localization signal.
3. The recombinant Sau Cas9 construct of claim 1 , wherein the promoter is an RNA Polymerase II dependent promoter/enhancer selected from the group consisting of EFS, hCMV, mCMV, CBA, hSynapsin, HSV TK, SV40 early and LSP.
4. The recombinant Sau Cas9 construct of claim 1 , having SEQ ID NO: 58.
5. A kit comprising the recombinant Sau Cas9 construct of claim 1 .
6. A kit comprising a recombinant construct comprising a recombinant Sau Cas9 construct comprising a promoter operably connected to a polynucleotide encoding a recombinant Sau Cas9 polypeptide, the polynucleotide comprising SEQ ID NO: 55, the recombinant construct comprising a first polynucleotide encoding a mammalian or viral tRNA operably connected to a second polynucleotide encoding at least a second portion of a single guide RNA capable of interacting with a Cas9 polypeptide, wherein the mammalian or viral tRNA is selected from the group consisting of a Gln tRNA, Pro tRNA, Gly tRNA, Asn tRNA, Cys tRNA, Glu tRNA, and a mouse gamma herpesvirus-68 (MHV68) tRNA.
7. The recombinant Sau Cas9 construct of claim 1 , further comprising an affinity tag.
8. The recombinant Sau Cas9 construct of claim 1 , further comprising a second promoter operably connected to a second polynucleotide encoding a single guide RNA.
9. The recombinant Sau Cas9 construct of claim 8 , wherein the single guide RNA comprises a first portion complementary to a strand of a target sequence of a DNA virus and a second portion capable of interacting with the Cas9 polypeptide.
10. The recombinant Sau Cas9 construct of claim 9 , wherein the DNA virus is classified in a family selected from the group consisting of hepadnaviridae, herpesviridae, papillomaviridae, and retroviridae.
11. The recombinant Sau Cas9 construct of claim 10 , wherein the DNA virus is a herpesviridae selected from the group consisting of herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2), Epstein Barr Virus (EBV), human cytomegalovirus (hCMV), Varicella zoster virus (VZV), and Kaposi's sarcoma associated herpesvirus (KSHV).
12. The recombinant Sau Cas9 construct of claim 10 , wherein the DNA virus is hepatitis B virus (HBV).
13. The recombinant Sau Cas9 construct of claim 10 , wherein the DNA virus is human immunodeficiency virus (HIV-1).
14. The recombinant Sau Cas9 construct of claim 9 , wherein the target sequence is selected from a gene encoding a reverse transcriptase or a surface antigen.
15. The recombinant Sau Cas9 construct of claim 8 , wherein the second promoter is a RNA Polymerase III promoter selected from the group consisting of a U6 promoter, a Gln tRNA, Pro tRNA, Gly tRNA, Asn tRNA, Cys tRNA, Glu tRNA, a mouse gamma herpesvirus-68 (MHV68) tRNA or any mammalian tRNA.
16. A viral vector comprising the recombinant Sau Cas9 construct of claim 1 .
17. The viral vector of claim 16 , wherein the viral vector is selected from the group consisting of a retrovirus, a lentivirus, an adenovirus or an adeno-associated virus.
18. The viral vector of claim 17 , wherein the viral vector is an adeno-associated virus (AAV).
19. A viral vector comprising the recombinant Sau Cas9 construct of claim 8 .
20. The viral vector of claim 19 , wherein the viral vector is selected from the group consisting of a retrovirus, a lentivirus, an adenovirus or an adeno-associated virus.
21. The viral vector of claim 20 , wherein the viral vector is an adeno-associated virus (AAV).